CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.

Chongqing Zhifei Biological Products Co., Ltd.

300122

CNE100000V20

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2025-01-24			5-day change	1st Jan Change
24.31 ^CNY	-0.04%		-2.37%	-7.57%

Dec. 09	Chongqing Zhifei Biological, GSK Adjust Terms of Cooperation Agreement	MT
Dec. 05	GSK, China's Zhifei Extend Shingles Shot Collaboration to 2034	DJ

Chongqing Zhifei Biological Products Co., Ltd. Approves Election of Zhang Xinrong as Independent Director

September 23, 2024 at 03:32 pm EDT

Chongqing Zhifei Biological Products Co., Ltd. at its EGM held on September 20, 2024, approved the election of Zhang Xinrong as independent director.

Latest news about Chongqing Zhifei Biological Products Co., Ltd.

Chongqing Zhifei Biological, GSK Adjust Terms of Cooperation Agreement	Dec. 09	MT
GSK, China's Zhifei Extend Shingles Shot Collaboration to 2034	Dec. 05	DJ
GSK expands deal with China's Zhifei to explore RSV vaccine collaboration	Dec. 05	RE
GSK plc and Zhifei Biological Products, Ltd Revise and Extend Strategic Vaccine Collaboration in China	Dec. 05	CI
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	24-10-25	CI
Chongqing Zhifei Biological Products Co., Ltd. Approves Election of Zhang Xinrong as Independent Director	24-09-23	CI
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	24-08-29	CI
Zhifei Biological Products' Unit Launches Clinical Trials on Pneumonia Vaccine	24-08-21	MT
Chongqing Zhifei Biological Products' 2023 Profit Rises 7%; Shares Plunge 12%	24-04-23	MT
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24-04-22	CI
Tranche Update on Chongqing Zhifei Biological Products Co., Ltd.'s Equity Buyback Plan announced on February 22, 2024.	24-03-28	CI
Chongqing Zhifei Biological Products Co., Ltd.'s Equity Buyback announced on February 22, 2024, has closed with 6,210,253 shares, for CNY 300.01 million.	24-03-27	CI
Chongqing Zhifei Biological Products Co., Ltd. announces an Equity Buyback for CNY 500 million worth of its shares.	24-02-22	CI
Chongqing Zhifei Biological Products Co., Ltd. authorizes a Buyback Plan.	24-02-21	CI
Zhifei Biological Falls After Merck Secures Nod to Market HPV Vaccine in China	24-01-10	MT
Zhifei Biological Products to Acquire Local Biopharma Firm, Expanding Into Metabolic Disease Treatments	23-11-27	MT
Chongqing Zhifei Biological Products Co., Ltd. signed a letter of intent to acquire Shanghai Polaris Biology Co., Ltd.	23-11-22	CI
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
GSK Signs Distribution Deal With China's Zhifei for Shingles Vaccine	23-10-09	MT
Chongqing Zhifei Biological Enters Exclusive Distribution Deal With GSK	23-10-09	MT
Trending : GSK Signs $3 Billion Shingles Vaccine Deal in China	23-10-09	DJ
GSK Strikes $3.06 Billion Shingles Vaccine Deal With China's Zhifei -- Update	23-10-09	DJ
European Midday Briefing : Oil Surges, Stocks Fall on Middle East Conflict	23-10-09	DJ
GSK inks agreement with Zhifei to promote shingles vaccine	23-10-09	AN
GSK Secures GBP2.5 Billion Partnership for Shingles Vaccine in China	23-10-09	MT

Chart Chongqing Zhifei Biological Products Co., Ltd.

Duration

Period

Chart Chongqing Zhifei Biological Products Co., Ltd.

300122: Dynamic Chart

Chongqing Zhifei Biological Products Co., Ltd. specializes in the research and development of vaccines for human use. The products include, in particular, bacterial vaccines for the prevention of meningitis, tuberculosis, rabies and influenza.

Employees

6,545

Sector

Pharmaceuticals

Calendar

2025-04-15 - Q1 2025 Earnings Release (Projected)

More about the company